These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29399289)

  • 1. Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis.
    Bhat V; Srinathan S; Pasini E; Angeli M; Chen E; Baciu C; Bhat M
    World J Hepatol; 2018 Jan; 10(1):155-165. PubMed ID: 29399289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of layers of data in hepatocellular carcinoma reveals pathway dependencies.
    Bhat M; Pasini E; Pastrello C; Rahmati S; Angeli M; Kotlyar M; Ghanekar A; Jurisica I
    World J Hepatol; 2021 Jan; 13(1):94-108. PubMed ID: 33584989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
    Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
    J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma.
    Udali S; Guarini P; Ruzzenente A; Ferrarini A; Guglielmi A; Lotto V; Tononi P; Pattini P; Moruzzi S; Campagnaro T; Conci S; Olivieri O; Corrocher R; Delledonne M; Choi SW; Friso S
    Clin Epigenetics; 2015; 7(1):43. PubMed ID: 25945129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes.
    Liu Z; Lin Y; Gao X; Mai R; Piao X; Ye J; Liang R
    Front Genet; 2020; 11():634. PubMed ID: 32670354
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
    Zheng Y; Huang Q; Ding Z; Liu T; Xue C; Sang X; Gu J
    Brief Bioinform; 2018 Jan; 19(1):101-108. PubMed ID: 27760737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma.
    Zhong D; Cen H
    Onco Targets Ther; 2017; 10():2501-2509. PubMed ID: 28507442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
    Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
    J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
    Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
    Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma.
    Hlady RA; Sathyanarayan A; Thompson JJ; Zhou D; Wu Q; Pham K; Lee JH; Liu C; Robertson KD
    Hepatology; 2019 Feb; 69(2):639-652. PubMed ID: 30136421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma.
    Liu M; Zhang L; Li H; Hinoue T; Zhou W; Ohtani H; El-Khoueiry A; Daniels J; O'Connell C; Dorff TB; Lu Q; Weisenberger DJ; Liang G
    Hepatology; 2018 Oct; 68(4):1412-1428. PubMed ID: 29774579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
    Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
    BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.
    Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H
    Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells.
    Abeni E; Salvi A; Marchina E; Traversa M; Arici B; De Petro G
    Int J Oncol; 2017 Jul; 51(1):128-144. PubMed ID: 28560380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
    Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.
    Calvisi DF; Ladu S; Gorden A; Farina M; Lee JS; Conner EA; Schroeder I; Factor VM; Thorgeirsson SS
    J Clin Invest; 2007 Sep; 117(9):2713-22. PubMed ID: 17717605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.